Search

Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...

Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...

Saul Ewing's Intellectual Property attorneys hosted a half-day virtual conference that addressed the following trends and challenges affecting businesses and innovators nationwide: Learning how to combat brand impersonation and cyber fraud with legal tools, cybersecurity measures, and cross-industry...

On October 7, 2024, the New Jersey Board of Public Utilities (the “Board”) issued a Notice of Proposed Substantial Changes to its previously proposed Community Solar Energy Program regulations (the “Proposed Changes”). The notice addresses prior comments and issues changes to the Board’s September...

BALTIMORE, (JUNE 12, 2024) – In joining Saul Ewing as a new partner, Carville B. Collins brings the firm’s clients more than 30 years of experience representing energy, water and other regulated businesses seeking a wide array of approvals from Maryland regulators. His practice also includes work in...

Understanding the complex intersection of environmental regulations intended to combat climate change between now and 2050 while responding to the U.S. tech economy’s exponential growth in energy demand will require collaboration between consumers, industry and government, and reliance upon a...

“PFAS” is an acronym for per- and polyfluoroalkyl substances, a family of thousands of widely used manmade chemicals that resist grease, oil, water and heat. PFAS has been used in firefighting foams, protective coatings and stain-resistant garments and carpets. PFAS are mobile and persistent; they...

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

With the rise of remote work, artificial intelligence, and the Internet of Things, data centers have become a critical piece of the digital economy. These facilities require reliable, high-quality electrical power, efficient cooling systems, robust physical and cybersecurity measures, and scalable...

When allegations of research fraud or misconduct come to light, the stakes for companies and research institutions could not be higher. Actions such as fabrication of scientific data, manipulation of research materials, and plagiarism can result in damaged reputations, loss of federal funding, and...

Justin Beyer brings more than 20 years of experience to his work as a litigator focusing on disputes involving trade secrets and non-compete agreements. This includes representing companies who need to protect or reacquire misappropriated information or wish to hire a competitor's former employee...

Ian Mahany-Horton helps corporate clients protect their intellectual property through drafting and prosecuting patent applications and advising them on patent portfolio strategies for their innovations. Ian has experience working on patent matters for mechanical, electrical, and software...

Al Chakravarty helps to protect and defend organizations and individuals from issues that are enforced by federal and state agencies, including regulatory and compliance issues, whistleblower complaints, national security concerns, allegations of anti-competitive behavior, executive or employee...

Stephen Genzer is a seasoned utilities lawyer who advises utility companies on legal and regulatory challenges connected with their significantly regulated industries. The issues he handles most frequently are in the ratemaking, operational and financial regulatory related areas. During a career...

Colleen Foley has more than two decades of experience handling a wide range of regulatory matters for public utilities and energy companies, including representing clients in nearly every major utility merger in New Jersey over that time span. Her work includes representations of water...

A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...

Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...

Eric Orlinsky concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity securities, mergers and acquisitions, purchases and sales of businesses. Eric also provides general...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...